129 related articles for article (PubMed ID: 20493173)
1. The phosphoCTD-interacting domain of Topoisomerase I.
Wu J; Phatnani HP; Hsieh TS; Greenleaf AL
Biochem Biophys Res Commun; 2010 Jun; 397(1):117-9. PubMed ID: 20493173
[TBL] [Abstract][Full Text] [Related]
2. Targeting to transcriptionally active loci by the hydrophilic N-terminal domain of Drosophila DNA topoisomerase I.
Shaiu WL; Hsieh TS
Mol Cell Biol; 1998 Jul; 18(7):4358-67. PubMed ID: 9632819
[TBL] [Abstract][Full Text] [Related]
3. Identification of a unique domain essential for Escherichia coli DNA topoisomerase III-catalysed decatenation of replication intermediates.
Li Z; Mondragón A; Hiasa H; Marians KJ; DiGate RJ
Mol Microbiol; 2000 Feb; 35(4):888-95. PubMed ID: 10692165
[TBL] [Abstract][Full Text] [Related]
4. The role of the carboxyl-terminal amino acid residues in Escherichia coli DNA topoisomerase III-mediated catalysis.
Zhang HL; Malpure S; Li Z; Hiasa H; DiGate RJ
J Biol Chem; 1996 Apr; 271(15):9039-45. PubMed ID: 8621552
[TBL] [Abstract][Full Text] [Related]
5. The C-terminal domain but not the tyrosine 723 of human DNA topoisomerase I active site contributes to kinase activity.
Rossi F; Labourier E; Gallouzi IE; Derancourt J; Allemand E; Divita G; Tazi J
Nucleic Acids Res; 1998 Jun; 26(12):2963-70. PubMed ID: 9611242
[TBL] [Abstract][Full Text] [Related]
6. The domain organization and properties of individual domains of DNA topoisomerase V, a type 1B topoisomerase with DNA repair activities.
Belova GI; Prasad R; Nazimov IV; Wilson SH; Slesarev AI
J Biol Chem; 2002 Feb; 277(7):4959-65. PubMed ID: 11733530
[TBL] [Abstract][Full Text] [Related]
7. Expanding the functional repertoire of CTD kinase I and RNA polymerase II: novel phosphoCTD-associating proteins in the yeast proteome.
Phatnani HP; Jones JC; Greenleaf AL
Biochemistry; 2004 Dec; 43(50):15702-19. PubMed ID: 15595826
[TBL] [Abstract][Full Text] [Related]
8. Thermotoga maritima-Escherichia coli chimeric topoisomerases. Answers about involvement of the carboxyl-terminal domain in DNA topoisomerase I-mediated catalysis.
Viard T; Cossard R; Duguet M; de La Tour CB
J Biol Chem; 2004 Jul; 279(29):30073-80. PubMed ID: 15140883
[TBL] [Abstract][Full Text] [Related]
9. Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factor.
Labourier E; Rossi F; Gallouzi IE; Allemand E; Divita G; Tazi J
Nucleic Acids Res; 1998 Jun; 26(12):2955-62. PubMed ID: 9611241
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of DNA topoisomerase I by the c-Abl tyrosine kinase confers camptothecin sensitivity.
Yu D; Khan E; Khaleque MA; Lee J; Laco G; Kohlhagen G; Kharbanda S; Cheng YC; Pommier Y; Bharti A
J Biol Chem; 2004 Dec; 279(50):51851-61. PubMed ID: 15448168
[TBL] [Abstract][Full Text] [Related]
11. Identification of a nucleolin binding site in human topoisomerase I.
Bharti AK; Olson MO; Kufe DW; Rubin EH
J Biol Chem; 1996 Jan; 271(4):1993-7. PubMed ID: 8567649
[TBL] [Abstract][Full Text] [Related]
12. Human topoisomerase I C-terminal domain fragment containing the active site tyrosine is a molten globule: implication for the formation of competent productive complex.
Punchihewa C; Dai J; Carver M; Yang D
J Struct Biol; 2007 Jul; 159(1):111-21. PubMed ID: 17434318
[TBL] [Abstract][Full Text] [Related]
13. RRM proteins interacting with the cap region of topoisomerase I.
Trzcińska-Daneluti AM; Górecki A; Czubaty A; Kowalska-Loth B; Girstun A; Murawska M; Lesyng B; Staroń K
J Mol Biol; 2007 Jun; 369(4):1098-112. PubMed ID: 17481653
[TBL] [Abstract][Full Text] [Related]
14. Raman and CD spectroscopy of recombinant 68-kDa DNA human topoisomerase I and its complex with suicide DNA-substrate.
Fleury F; Ianoul A; Kryukov E; Sukhanova A; Kudelina I; Wynne-Jones A; Bronstein IB; Maizieres M; Berjot M; Dodson GG; Wilkinson AJ; Holden JA; Feofanov AV; Alix AJ; Jardillier JC; Nabiev I
Biochemistry; 1998 Oct; 37(41):14630-42. PubMed ID: 9772192
[TBL] [Abstract][Full Text] [Related]
15. Toprim--a conserved catalytic domain in type IA and II topoisomerases, DnaG-type primases, OLD family nucleases and RecR proteins.
Aravind L; Leipe DD; Koonin EV
Nucleic Acids Res; 1998 Sep; 26(18):4205-13. PubMed ID: 9722641
[TBL] [Abstract][Full Text] [Related]
16. Two separate conserved domains of eukaryotic DNA topoisomerase I bind to each other and reconstitute enzymatic activity.
Park H; Sternglanz R
Chromosoma; 1998 Jun; 107(3):211-5. PubMed ID: 9639660
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of a bacterial type IB DNA topoisomerase reveals a preassembled active site in the absence of DNA.
Patel A; Shuman S; Mondragón A
J Biol Chem; 2006 Mar; 281(9):6030-7. PubMed ID: 16368685
[TBL] [Abstract][Full Text] [Related]
18. Conservation of structure and mechanism between eukaryotic topoisomerase I and site-specific recombinases.
Cheng C; Kussie P; Pavletich N; Shuman S
Cell; 1998 Mar; 92(6):841-50. PubMed ID: 9529259
[TBL] [Abstract][Full Text] [Related]
19. Antibody specificities of Thai and Australian scleroderma sera with topoisomerase I recombinant fusion proteins.
Cram DS; Fisicaro N; McNeilage LJ; Coppel RL; Harrison LC
J Immunol; 1993 Dec; 151(12):6872-81. PubMed ID: 7505017
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of the Set2-Rpb1 interacting domain of human Set2 and its interaction with the hyperphosphorylated C-terminal domain of Rpb1.
Li M; Phatnani HP; Guan Z; Sage H; Greenleaf AL; Zhou P
Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17636-41. PubMed ID: 16314571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
